Clinical Trial Update: A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing telbivudine (LdT) versus lamivudine in adults with decompensated chronic hepatitis B and cirrhosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Cirrhosis

Drugs mentioned

• Lamivudine (lamivudine)
• Telbivudine (telbivudine)

Snippet

Sponsor: Mayo Clinic | Conditions: Hepatitis B, Cirrhosis | Phase 3 | Status: COMPLETED